All ProductsDisplaying Products Alphabetically by Name (L)
| Cat. No. | 产品名称/活性 |
|---|---|
| 3066 | L 006235 |
| Potent cathepsin K inhibitor | |
| 5085 | L 012 sodium salt |
| Chemiluminescent ROS and RNS indicator | |
| 4013 | L 760735 |
| High affinity NK1 antagonist | |
| 6251 | L Moses dihydrochloride |
| High affinity and selective PCAF bromodomain inhibitor | |
| 1382 | L-152,804 |
| Potent, selective non-peptide NPY Y5 receptor antagonist | |
| 2514 | L-161,982 |
| Selective EP4 receptor antagonist | |
| 2311 | L-168,049 |
| Potent, orally active human glucagon receptor antagonist | |
| 2767 | L-365,260 |
| Selective CCK2 antagonist | |
| 2641 | L-368,899 hydrochloride |
| Potent, non-peptide oxytocin receptor antagonist | |
| 2410 | L-371,257 |
| Potent and selective oxytocin receptor antagonist | |
| 3086 | L-651,582 |
| Non-selective Ca2+ channel blocker | |
| 1327 | L-655,708 |
| Benzodiazepine inverse agonist; selective for α5-containing GABAA receptors | |
| 2627 | L-685,458 |
| Potent and selective γ-secretase inhibitor | |
| 0742 | L-689,560 |
| Highly potent NMDA antagonist | |
| 0681 | L-690,330 |
| Inositol monophosphatase inhibitor | |
| 0907 | L-701,324 |
| NMDA antagonist; acts at glycine site | |
| 1145 | L-733,060 hydrochloride |
| Potent NK1 antagonist | |
| 1004 | L-741,742 hydrochloride |
| Highly selective D4 antagonist | |
| 1003 | L-741,626 |
| High affinity D2 antagonist | |
| 1002 | L-745,870 trihydrochloride |
| Highly selective D4 antagonist | |
| 2760 | L-748,337 |
| Selective β3 antagonist | |
| 3342 | L-798,106 |
| Potent and highly selective EP3 antagonist | |
| 1980 | L-817,818 |
| Potent and selective sst5 agonist | |
| 3250 | L-838,417 |
| GABAA partial agonist; displays subtype selectivity | |
| 6954 | L-Buthionine sulfoximine |
| Irreversible γ-glutamylcysteine synthetase (γ-GCS) inhibitor; induces ferroptosis | |
| 3788 | L-DOPA |
| Dopamine precursor | |
| 6146 | LAP |
| Photocrosslinker for hydrogels | |
| 7420 | LC 2 |
| Selective KRAS Degrader (PROTAC®) | |
| 7421 | LC 2 Epimer |
| Negative control for LC 2 (Cat. No. 7420) | |
| 5592 | LCB 03-0110 dihydrochloride |
| Potent c-SRC kinase inhibitor; also inhibits DDR2, BTK and Syk | |
| 7178 | LCL 161, phenol |
| Functionalized IAP ligand for PROTACs | |
| 5631 | LDN 193188 |
| Inhibitor of phosphatidylcholine transfer protein (PC-TP) | |
| 6053 | LDN 193189 dihydrochloride |
| Potent and selective ALK2 and ALK3 inhibitor; inhibits BMP4 signaling; promotes neural induction of hPSCs | |
| 8150 | LDN 193189 in solution |
| Sterile-filtered 10 mM solution of LDN 193189 pre-dissolved in water | |
| TB6053-GMP | LDN 193189 |
| LDN 193189 synthesized to cGMP guidelines | |
| 7020 | LDV |
| α4β1 (VLA-4) ligand | |
| 4577 | LDV FITC |
| Fluorescent ligand for α4β1 (VLA-4) | |
| 5826 | LEI 101 hydrochloride |
| Potent and selective CB2 partial agonist; orally biovailable | |
| 7407 | LEI 401 |
| High affinity N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor | |
| 1300 | LFM-A13 |
| Potent, selective BTK inhibitor | |
| 5920 | LG 100268 |
| Potent and selective RXR agonist; also activates RXR/PPARγ heterodimers | |
| 8095 | LIH 383 |
| Atypical chemokine receptor (ACKR3) agonist | |
| 4745 | LIMKi 3 |
| Potent LIM kinase inhibitor; antitumor | |
| 6754 | LJI308 |
| Potent pan-RSK inhibitor | |
| 5213 | LL 37 |
| Antimicrobial peptide derivative of human cathelicidin | |
| 7813 | LL-K9-3 |
| Selective HyT-based degrader of the CDK9-cyclin T1 complex | |
| 4607 | LM 22A4 |
| Potent TrkB agonist | |
| 6037 | LM22B 10 |
| TrkB and TrkC agonist; brain penetrant | |
| 6510 | LNT 1 |
| Potent flap endonuclease 1 (FEN1) inhibitor; induces DNA damage response | |
| 6691 | LP 922056 |
| Notum inhibitor; activates Wnt signaling | |
| 5496 | LP 99 |
| Selective BRD7 and BRD9 inhibitor | |
| 4273 | LRRK2-IN-1 |
| Potent and selective LRRK2 inhibitor | |
| 5275 | LSN 2463359 |
| Potent and selective positive allosteric modulator of mGlu5 receptors | |
| 7959 | LSN 3318839 |
| Glucagon-like peptide-1 receptor (GLP1-R) positive allosteric modulator | |
| 5834 | LTURM 34 |
| Potent DNA-PK inhibitor; also increases CRISPR-Cas9 deletion efficiency | |
| 3562 | LU AA33810 |
| Potent NPY Y5 receptor antagonist | |
| 4603 | LUF 5834 |
| Potent adenosine A2A and A2B receptor partial agonist | |
| 6322 | LW 6 |
| Malate dehydrogenase-2 (MDH2) inhibitor; also inhibits HIF-1α | |
| 7027 | LY 2033298 |
| Selective positive allosteric modulator of M4 receptors; active in vivo; antipsychotic | |
| 4141 | LY 2087101 |
| Allosteric potentiator of α7, α4β2 and α4β4 nAChRs | |
| 7864 | LY 2109761 |
| Selective TGF-β kinase inhibitor | |
| 6964 | LY 2119620 |
| Positive allosteric modulator of M2 and M4 receptors | |
| 3397 | LY 2365109 hydrochloride |
| Potent and selective GlyT1 inhibitor | |
| 2208 | LY 255283 |
| Selective, competitive BLT2 receptor antagonist | |
| 6454 | LY 2603618 |
| Potent and selective Chk1 inhibitor | |
| 4081 | LY 266097 hydrochloride |
| Selective 5-HT2B antagonist | |
| 3077 | LY 272015 hydrochloride |
| High affinity 5-HT2B antagonist; orally active | |
| 1524 | LY 288513 |
| Selective CCK2 antagonist | |
| 7081 | LY 2886721 Hydrochloride |
| Potent and selective β-secretase (BACE) inhibitor | |
| 1130 | LY 294002 hydrochloride |
| Prototypical PI 3-kinase inhibitor; also inhibits other kinases | |
| 3078 | LY 310762 hydrochloride |
| Selective 5-HT1D antagonist | |
| 1209 | LY 341495 |
| Highly potent and selective group II mGlu antagonist | |
| 4062 | LY 341495 disodium salt |
| Potent and selective group II mGlu antagonist; disodium salt of LY 341495 (Cat. No. 1209) | |
| 2451 | LY 344864 hydrochloride |
| Potent and selective 5-HT1F agonist | |
| 3246 | LY 354740 |
| Potent and highly selective group II mGlu agonist | |
| 1237 | LY 367385 |
| Selective mGlu1a antagonist | |
| 2453 | LY 379268 |
| Highly selective group II mGlu agonist | |
| 5064 | LY 379268 disodium salt |
| Selective group II mGlu agonist; sodium salt of LY 379268 (Cat. No. 2453) | |
| 5297 | LY 404187 |
| Selective positive allosteric modulator of AMPA receptors | |
| 6559 | LY 450139 |
| γ-secretase pseudo-inhibitor | |
| 2390 | LY 456236 hydrochloride |
| Selective mGlu1 antagonist | |
| 3283 | LY 487379 hydrochloride |
| Selective positive allosteric modulator of mGlu2 receptors | |
| 6617 | LYN 1604 dihydrochloride |
| Potent UNC-51-like kinase 1 (ULK1) agonist | |
| 8888 | LaKe |
| Orally bioavailable prodrug metabolite, undergoes hydrolytic conversion to yield (S)-lactate and (R)-1,3-butanediol in cells | |
| 7942 | Lac-Phe |
| Metabolite generated by cytosol nonspecific dipeptidase (CNDP2) during intense exercise | |
| 2267 | Lactacystin |
| Cell-permeable, potent and selective proteasome inhibitor | |
| 6098 | Lalistat 1 |
| Potent and selective LAL inhibitor | |
| 6099 | Lalistat 2 |
| Selective LAL inhibitor | |
| 1611 | Lamotrigine |
| Inhibits glutamate release. Anticonvulsant | |
| 2289 | Lamotrigine isethionate |
| Inhibits glutamate release. Water-soluble salt of lamotrigine (Cat. No. 1611) | |
| 6811 | Lapatinib |
| Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor | |
| 7343 | Laropiprant |
| Potent and selective prostaglandin D2 receptor antagonist | |
| 3973 | Latrunculin A |
| Inhibitor of actin assembly and polymerization | |
| 3974 | Latrunculin B |
| Inhibitor of actin polymerization | |
| 7275 | Laurdan |
| Polarity sensitive lipid membrane fluorescent probe. Used for: imaging lipid rafts. Application: fluorescent microscopy | |
| 2460 | Lazabemide hydrochloride |
| Selective MAO-B inhibitor | |
| 6305 | Lenalidomide |
| Cereblon binder; induces ubiquitination and degradation of CK1α by E3 ubiquitin ligase | |
| 7075 | Lenalidomide 4'-PEG1-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7513 | Lenalidomide 4'-PEG1-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7093 | Lenalidomide 4'-PEG2-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7514 | Lenalidomide 4'-PEG2-azide |
| Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
| 7076 | Lenalidomide 4'-PEG3-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 7516 | Lenalidomide 4'-alkylC3-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7517 | Lenalidomide 4'-alkylC5-azide |
| Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
| 7677 | Lenalidomide 5'-amine |
| Cereblon ligand with terminal amine for onward chemistry | |
| 7472 | Lenalidomide 5'-piperazine |
| Cereblon ligand with terminal piperazine for onward chemistry | |
| 7473 | Lenalidomide 5'-piperazine-4-methylpiperidine |
| Cereblon ligand with terminal piperidine for onward chemistry | |
| 8848 | Lenalidomide 5'-piperazine-7'-methoxy |
| Cereblon ligand with terminal piperazine for onward chemistry | |
| 3395 | Lestaurtinib |
| JAK2, FLT3 and TrkA inhibitor; also inhibits AurA and AurB | |
| 4382 | Letrozole |
| Potent, reversible non-steroidal aromatase inhibitor | |
| 2307 | Leukotriene B4 |
| BLT1/BLT2 receptor agonist and potent chemotactic factor | |
| 1167 | Leupeptin hemisulfate |
| Inhibits trypsin-like/cysteine proteases | |
| 1378 | Levcromakalim |
| Kir6 (KATP) channel opener; active enantiomer of Cromakalim | |
| 2839 | Levetiracetam |
| Binds SV2A; antiepileptic | |
| 2705 | Liarozole dihydrochloride |
| Blocks retinoic acid metabolism | |
| 3865 | Licarbazepine |
| Active metabolite of oxcarbazepine (Cat. No. 3864) | |
| 3057 | Lidocaine |
| Na+ channel blocker | |
| 7743 | Linifanib |
| Potent inhibitor of PDGFRβ, KDR, FLT3 and CSF-1R | |
| 1999 | Linopirdine dihydrochloride |
| KV7 (KCNQ) channel blocker | |
| 7652 | Linsitinib |
| Potent and selective dual inhibitor of the IGF-1 receptor and insulin receptor | |
| 6113 | Liproxstatin-1 hydrochloride |
| Potent ferroptosis inhibitor | |
| 6517 | Liraglutide |
| Highly potent, long-acting GLP-1 receptor agonist | |
| 4052 | Lisuride maleate |
| Dopamine agonist; antiparkinson's agent | |
| 4359 | Lomeguatrib |
| MGMT inhibitor | |
| 7492 | Lomitapide mesylate |
| Potent microsomal triglyceride transfer protein (MTP) inhibitor | |
| 6265 | Lonafarnib |
| Potent farnesyltransferase inhibitor | |
| 1646 | Lonidamine |
| Mitochondrial hexokinase inhibitor | |
| 7052 | Lopinavir |
| Highly potent and selective HIV-1 protease inhibitor | |
| 1295 | Loreclezole hydrochloride |
| Subtype-selective GABAA modulator | |
| 3798 | Losartan potassium |
| Selective, non-peptide AT1 antagonist | |
| 1530 | Lovastatin |
| Potent HMG-CoA reductase inhibitor | |
| 3036 | Loxiglumide |
| CCK1 antagonist; active in vivo | |
| 5427 | D-Luciferin sodium salt |
| Firefly luciferase substrate; cell permeable. | |
| 2874 | Luteolin |
| Anti-inflammatory, antioxidant and free radical scavenger | |
| 0877 | Luzindole |
| Competitive melatonin MT1/MT2 antagonist |
Tocris Products by Catalog Number
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900